XML 79 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Nov. 02, 2019
Accounting Policies [Abstract]  
Schedule of new accounting pronouncements and changes in accounting principles As a result of the adoption of ASU 2014-09, the Company changed its accounting policy for revenue recognition and recognizes revenue from product sales to its customers and distributors when title passes, which is generally upon shipment. Prior to the adoption of ASU 2014-09, revenue and the related cost of sales on shipments to certain distributors were deferred until the distributor resold the products to their end customers. See Note 2n, Revenue Recognition, in these Notes to
Consolidated Financial Statements for the details of the Company’s revenue recognition policies. The adoption of ASU 2014-09 impacted the Company’s consolidated statements of income and consolidated balance sheets but did not impact its consolidated statements of cash flows, with the exceptions of net income and reclassifications within adjustments to reconcile net income to cash provided by operations, and did not impact the consolidated statement of shareholders' equity, with the exceptions of retained earnings and net income. As shown in the tables below, pursuant to the guidance in ASU 2014-09, the Company restated its historical financial results to be consistent with the standard. Accordingly, the amounts for fiscal 2019, fiscal 2018 and fiscal 2017 periods presented in this Form 10-K reflect the impact of ASU 2014-09.
In addition, the Company adopted ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost in the first quarter of fiscal 2019. Under this ASU, the service cost component of net periodic benefit cost is recorded in Cost of sales, Research and development, Selling, marketing, general and administrate expenses, while the remaining components are recorded to Other, net within the Company's consolidated statements of income. As such, the prior year amounts have been reclassified to provide comparable presentation in line with the guidance in ASU 2017-07 based on amounts previously disclosed for the various components of net periodic pension cost. See Note 11, Retirement Plans, in these Notes to Consolidated Financial Statements for more information on the adoption of ASU 2017-07.
The tables below reconcile the impact of ASU 2014-09 and ASU 2017-07 on the consolidated statements of income:
Year Ended November 3, 2018
Consolidated Statement of IncomeAs Reported  Impact of Adoption of ASU 2014-09  Impact of Adoption of ASU 2017-07  As Adjusted  
Revenue$6,200,942  $23,747  $—  $6,224,689  
Cost of sales1,967,640  6,950  (297) 1,974,293  
Gross margin4,233,302  16,797  297  4,250,396  
Operating expenses:
Research and development1,165,410  —  (363) 1,165,047  
Selling, marketing, general and administrative695,937  —  (397) 695,540  
Amortization of intangibles428,902  —  —  428,902  
Special charges61,318  —  —  61,318  
2,351,567  —  (760) 2,350,807  
Operating income1,881,735  16,797  1,057  1,899,589  
Nonoperating expense (income):
Interest expense253,589  —  —  253,589  
Interest income(9,383) —  —  (9,383) 
Other, net(988) —  1,057  69  
243,218  —  1,057  244,275  
Income before income taxes1,638,517  16,797  —  1,655,314  
Provision for income taxes143,085  5,249  —  148,334  
Net income$1,495,432  $11,548  $—  $1,506,980  
Shares used to compute earnings per common share – basic370,430  —  —  370,430  
Shares used to compute earnings per common share – diluted374,938  —  —  374,938  
Basic earnings per common share$4.02  $0.03  $—  $4.05  
Diluted earnings per common share$3.97  $0.03  $—  $4.00  
Year Ended October 28, 2017
Consolidated Statement of IncomeAs Reported  Impact of Adoption of ASU 2014-09  Impact of Adoption of ASU 2017-07  As Adjusted  
Revenue$5,107,503  $138,851  $—  $5,246,354  
Cost of sales2,045,907  32,589  (383) 2,078,113  
Gross margin3,061,596  106,262  383  3,168,241  
Operating expenses:
Research and development968,602  —  (469) 968,133  
Selling, marketing, general and administrative691,046  —  (513) 690,533  
Amortization of intangibles297,351  —  —  297,351  
Special charges49,463  —  —  49,463  
2,006,462  —  (982) 2,005,480  
Operating income1,055,134  106,262  1,365  1,162,761  
Nonoperating expense (income):
Interest expense250,840  —  —  250,840  
Interest income(30,333) —  —  (30,333) 
Other, net6,142  —  1,365  7,507  
226,649  —  1,365  228,014  
Income before income taxes828,485  106,262  —  934,747  
Provision for income taxes101,226  28,142  —  129,368  
Net income$727,259  $78,120  $—  $805,379  
Shares used to compute earnings per common share – basic346,371  —  —  346,371  
Shares used to compute earnings per common share – diluted350,484  —  —  350,484  
Basic earnings per common share$2.09  $0.23  $—  $2.32  
Diluted earnings per common share$2.07  $0.22  $—  $2.29  
The impact on the Company's previously reported consolidated balance sheet line items is as follows:
November 3, 2018
As ReportedImpact of Adoption of ASU 2014-09As Adjusted
Deferred tax assets$21,078  $(11,413) $9,665  
Deferred income on shipments to distributors, net$487,417  $(487,417) $—  
Accrued liabilities$497,080  $133,027  $630,107  
Deferred income taxes$927,065  $63,344  $990,409  
Retained earnings$5,703,064  $279,633  $5,982,697  
In addition, in the first quarter of fiscal 2019, the Company adopted ASU 2016-16, Income Taxes (Topic 740) (ASU 2016-16) using the modified retrospective method with a cumulative-effect adjustment directly to retained earnings. ASU 2016-16 requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The adoption of ASU 2016-16 resulted in the following cumulative-effect increase in the Company's deferred tax assets, deferred tax liabilities and retained earnings as follows:
November 4, 2018
Beginning Balance November 3, 2018 as AdjustedImpact of Adoption of ASU 2016-16Balance November 4, 2018
Deferred tax assets$9,665  $1,655,129  $1,664,794  
Deferred income taxes$990,409  $1,324,103  $2,314,512  
Retained earnings$5,982,697  $331,026  $6,313,723  
Cash and cash equivalents and short term investments
The components of the Company’s cash and cash equivalents as of November 2, 2019 and November 3, 2018 were as follows:
20192018
Cash and cash equivalents:  
Cash$152,432  $147,629  
Available-for-sale416,890  598,962  
Held-to-maturity79,000  70,000  
Total cash and cash equivalents$648,322  $816,591  
Supplemental cash flow statement Information
201920182017
Cash paid during the fiscal year for:   
Income taxes$205,762  $211,473  $868,492  
Interest$216,143  $233,436  $183,117  
Inventories
Inventories at November 2, 2019 and November 3, 2018 were as follows:
20192018
Raw materials$35,447  $30,511  
Work in process400,409  375,908  
Finished goods174,030  180,341  
Total inventories$609,886  $586,760  
Useful lives of property, plant and equipment Depreciation is based on the following ranges of estimated useful lives:
Buildings
Up to 30 years
Machinery & equipment
3-10 years
Office equipment
3-10 years
Leasehold improvements
7-20 years
Changes in goodwill
The following table presents the changes in goodwill during fiscal 2019 and fiscal 2018:
20192018
Balance at beginning of year$12,252,604  $12,217,455  
Acquisition of Linear (Note 6)—  1,647  
Goodwill adjustment related to other acquisitions (1)6,702  36,558  
Foreign currency translation adjustment(2,426) (3,056) 
Balance at end of year$12,256,880  $12,252,604  
_______________________________________
(1) Represents goodwill related to other acquisitions that were not material to the Company on either an individual or aggregate basis.
Intangible Assets
As of November 2, 2019 and November 3, 2018, the Company’s intangible assets consisted of the following:
 November 2, 2019November 3, 2018
 Gross Carrying
Amount 		Accumulated
Amortization		Gross Carrying
Amount		Accumulated
Amortization
Customer relationships$4,696,562  $1,284,256  $4,697,716  $867,207  
Technology-based1,145,283  385,618  1,114,080  243,350  
Trade-name73,417  28,164  74,031  17,846  
IPR&D —  —  20,768  —  
Total (1) (2)
$5,915,262  $1,698,038  $5,906,595  $1,128,403  
_______________________________________
(1) Foreign intangible asset carrying amounts are affected by foreign currency translation.
(2) Increases in intangible assets primarily relate to acquisitions that were not material to the Company on either an individual or aggregate basis. Intangible assets, along with the related accumulated amortization, are removed from the table above at the end of the fiscal year they become fully amortized.
Schedule of expected annual amortization expense
The Company expects annual amortization expense for intangible assets as follows:
Fiscal YearAmortization Expense
2020$575,004  
2021$574,404  
2022$571,474  
2023$548,276  
2024$486,376  
Fair value of hedging instruments The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s consolidated balance sheets as of November 2, 2019 and November 3, 2018 were as follows: 
Fair Value At
Balance Sheet LocationNovember 2, 2019November 3, 2018
Forward foreign currency exchange contractsPrepaid expenses and other current assets  $65  $—  
Forward foreign currency exchange contractsAccrued liabilities  $—  $6,934  
Offsetting Assets Liabilities The following table presents the gross amounts of the Company's derivative assets and liabilities and the net amounts recorded in the Company's consolidated balance sheets as of November 2, 2019 and November 3, 2018:
 November 2, 2019November 3, 2018
Gross amount of recognized liabilities$(2,828) $(8,054) 
Gross amounts of recognized assets offset in the consolidated balance sheets2,828  904  
Net liabilities presented in the consolidated balance sheets$—  $(7,150) 
Fair value of financial assets and liabilities The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components, that were accounted for at fair value on a recurring basis as of November 2, 2019 and November 3, 2018. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of November 2, 2019 and November 3, 2018, the Company held $231.4 million and $217.6 million, respectively, of cash and held-to-maturity investments that were excluded from the tables below.
 November 2, 2019
 Fair Value measurement at
Reporting Date using:		 
 Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Total
Assets
Cash equivalents:
Available-for-sale:
Government and institutional money market funds$416,890  $—  $416,890  
Other assets:
Deferred compensation investments48,302  —  48,302  
Total assets measured at fair value$465,192  $—  $465,192  
Liabilities
Interest rate derivatives—  138,798  138,798  
Total liabilities measured at fair value$—  $138,798  $138,798  

 November 3, 2018
 Fair Value measurement at
Reporting Date using:		 
 Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Total
Assets
Cash equivalents:
Available-for-sale:
Government and institutional money market funds$394,076  $—  $394,076  
Corporate obligations (1)—  204,886  204,886  
Other assets:
Deferred compensation investments41,001  —  41,001  
Interest rate derivatives—  1,436  1,436  
Total assets measured at fair value$435,077  $206,322  $641,399  
Liabilities
Forward foreign currency exchange contracts (2)—  7,150  7,150  
Total liabilities measured at fair value$—  $7,150  $7,150  
 _______________________________________
(1)The amortized cost of the Company’s investments classified as available-for-sale as of November 3, 2018 was $205.0 million.
(2)The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of these Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements.
Schedule of debt
The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The carrying amounts of the term loan approximates fair value. The term loan is classified as Level 2 measurements according to the fair value hierarchy. The fair values of the senior unsecured notes debt are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. See Note 14, Debt, of these Notes to Consolidated Financial Statements for further discussion related to outstanding debt.
November 2, 2019November 3, 2018
Principal Amount OutstandingFair Value Principal Amount Outstanding Fair Value
3-Year term loan, due March 2022$925,000  $925,000  $—  $—  
3-Year term loan, due March 2020 —  —  425,000  425,000  
5-Year term loan, due March 2022—  —  1,350,000  1,350,000  
2020 Notes, due March 2020300,000  300,872  300,000  298,147  
2021 Notes, due January 2021450,000  454,634  450,000  444,568  
2021 Notes, due December 2021400,000  402,591  400,000  386,375  
2023 Notes, due June 2023500,000  511,190  500,000  479,189  
2023 Notes, due December 2023550,000  567,159  550,000  529,120  
2025 Notes, due December 2025850,000  914,567  850,000  829,611  
2026 Notes, due December 2026900,000  940,192  900,000  848,027  
2036 Notes, due December 2036250,000  270,891  250,000  232,627  
2045 Notes, due December 2045400,000  491,439  400,000  407,984  
Total Debt$5,525,000  $5,778,535  $6,375,000  $6,230,648  
Components of accumulated other comprehensive (loss) The components of AOCI at November 2, 2019 and November 3, 2018 consisted of the following, net of tax:
Foreign currency translation adjustmentUnrealized holding gains (losses) on available for sale securities Unrealized holding gains (losses) on derivativesPension plansTotal
November 3, 2018$(28,711) $(10) $(14,355) $(15,364) $(58,440) 
Other comprehensive (loss) income before reclassifications(1,365) 10  (140,728) (31,082) (173,165) 
Amounts reclassified out of other comprehensive loss—  —  9,185  1,004  10,189  
Tax effects—  —  27,883  5,734  33,617  
Other comprehensive (loss) income(1,365) 10  (103,660) (24,344) (129,359) 
November 2, 2019$(30,076) $—  $(118,015) $(39,708) $(187,799) 
Reclassification out of accumulated other comprehensive income
The amounts reclassified out of AOCI into the consolidated statements of income, with presentation location during each period were as follows:

Comprehensive Income Component20192018Location
Unrealized holding gains (losses) on derivatives
    Currency forwards $1,736  $396  Cost of sales
2,956  (462) Research and development
3,056  (317) Selling, marketing, general and administrative
     Interest rate derivatives1,437  (1,324) Interest expense
9,185  (1,707) Total before tax
(1,518) 94  Tax
$7,667  $(1,613) Net of tax
Amortization of pension components
     Transition obligation$—  $10  (1)
     Prior service credit and curtailment recognition—  1  (1)
     Actuarial losses and settlement recognition1,004  1,621  (1)
1,004  1,632  Total before tax
(248) (395) Tax
$756  $1,237  Net of tax
Total amounts reclassified out of AOCI, net of tax$8,423  $(376) 
_______________________________________
(1)The amortization of pension components is included in the computation of net periodic pension cost. See Note 11, Retirement Plans, of these Notes to Consolidated Financial Statements for further information.
Computation of basic and diluted earnings per share
The following table sets forth the computation of basic and diluted earnings per share:
20192018 (1)2017 (1)
Net income$1,363,011  $1,506,980  $805,379  
Less: income allocated to participating securities3,229  5,909  2,243  
Net income allocated to common shareholders$1,359,782  $1,501,071  $803,136  
Basic shares:   
Weighted-average shares outstanding369,133  370,430  346,371  
Earnings per common share basic$3.68  $4.05  $2.32  
Diluted shares:   
Weighted-average shares outstanding369,133  370,430  346,371  
Assumed exercise of common stock equivalents3,738  4,508  4,113  
Weighted-average common and common equivalent shares372,871  374,938  350,484  
Earnings per common share diluted$3.65  $4.00  $2.29  
Anti-dilutive shares related to:   
Outstanding stock options826  1,649  1,527  
_______________________________________
(1)Balances have been restated to reflect the adoption of ASU 2014-09. See Note 2a, Principles of Consolidation, in the Notes to Consolidated Financial Statements.